Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

News and Trends 9 Jun 2016

German Biotech launches Phase II in a hot Target for Inflammation

InflaRx has treated the first patient in a new Phase II trial, which is studying the potential of its anti-complement antibody in avoiding immunological complications after complex cardiac surgery – a big unmet need. It is competing with world most expensive drug Soliris from Alexion (US). Based in Jena (Germany), InflaRx specializes in developing new […]

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 Jun 2016

Brain Cell Transplant could help with incurable Neurodegenerative Disease

Researchers from Copenhagen and the US have succeeded in slowing the progression of Huntington’s disease in mice with a transplant of healthy human brain cells. This provides a new route to tackle this incurable fatal disease. Cell therapies are promising for some of the most serious diseases, from their role in cancer treatment (one of the […]

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 Jun 2016

Biotech, France and L’Oréal Team up for World First Biofuel Plant using Beets

The Investissements d’Avenir programme (a French government initiative) is providing €9M to both Global Bioenergies and IBN-One, as part of an project involving Cristal Union (the agro-business for Beet production) and L’Oréal (the cosmetics Giant). Together, they will develop the first commercial plant producing bio-sourced isobutene worldwide. Broken down into €5.7M for Global Bioenergies; €3.3M for IBN-One, the […]

June 9, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 8 Jun 2016

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting

Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why? It’s where one of the biggest oncology events happens – the ASCO Annual Meeting 2016. Shortly after the AACR annual meeting (with presentations from several European Biotechs), it’s time for the ASCO annual meeting. Hosted by the American Society of Clinical […]

June 8, 2016 - 7 minutesmins - By Denise Neves Gameiro

News and Trends 7 Jun 2016

New Massive €250M Investment Fund Closed for European Biotech

Life Sciences Partners (LSP) has closed its new life sciences fund, ‘LSP5’. The fund surpassed its €152M target and reached the ‘hard cap’ of €250M, making it one of the largest life sciences funds in the EU. LSP is one of the oldest and most successful Biotech investors in Europe. It claims over 25% return […]

June 7, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 7 Jun 2016

German Biotech partners up in the US for scalable viral vector production in Gene Therapy

Cevec is joining forces with US-based Paragon. The objective is to make Cevec’s scalable CAP expression technology the industry standard for glycoproteins and viral vectors in gene therapies. Based in Cologne (Germany), Cevec tackles with its human cell-based expression systems (CAP-GT and CAP-Go) two big challenges in Biotech manufacturing – industrial scale production of viral vectors […]

June 7, 2016 - 4 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

News and Trends 7 Jun 2016

Zurich is not all about Money – here are 9 Biotechs proving it!

The biggest city in Switzerland, Zurich, is one of Europe’s top financial centers and home to the SIX Swiss Exchange (SWX). It’s also one of the most expensive cities in Europe to live in (as my Swiss colleague Claire could confirm). With so much money nearby, how does the local Biotech ecosystem looks like? The biggest Biotech/mid-size Pharma in […]

June 7, 2016 - 5 minutesmins - By Denise Neves Gameiro

News and Trends 7 Jun 2016

Understand which transporters are involved in a drug’s absorption, distribution & excretion

How can you build the best case for a new drug application to the regulatory agencies? Preclinical studies are a crucial part in determining the pharmacokinetics of a drug – and more specifically how it is going to interact with drug transporters. So reaching out to the leading provider and consultant in this area (with strong […]

June 7, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 6 Jun 2016

‘Living’ Therapeutics in Boston attract major French Microbiome Money

Health for Life Capital, managed by Seventure Partners, has invested $8M (€7.15M) as part of a $50M financing round completed by Boston-based Vedanta Biosciences. This seems to be a great match between one of the most influential Microbiome investors and one of the most successful Microbiome biotechs. The basis for the financing is a live-bioproduct from […]

June 6, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 6 Jun 2016

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

Numab and Intarcia have achieved key milestones in the development of therapeutic antibody fragments. This collaboration could span the next generation of implantable drug delivery tech for diabetes, obesity and autoimmune diseases. Based in Wädenswill (near Zurich), Numab is developing antibody-based therapeutics. With its ultra-high throughput technology, it can find rare molecules with big therapeutic potential that are […]

June 6, 2016 - 2 minutesmins - By Denise Neves Gameiro

car t cancer immunooncology biotech labiotech refresh georges rawadi

News and Trends 6 Jun 2016

CAR-T: “This is totally different from what everyone else is doing”

And on the topic of CAR-T, Joachim spoke to Georges Rawadi from the Belgium based biotech, Celyad. Having originally been built on research into a cell therapy for cardiology, Celyad started back in 2007. Now Rawadi explained it’s coming to the end of a cycle for the Cardiology programme. So naturally, they asked what next? Well – […]

June 6, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 4 Jun 2016

BioArt : Nurit Bar-Shai’s ‘Chemical Tweets’ and the Social Life of Bacteria

Nurit Bar-Shai is an artist and co-founder of bio-hacking lab Genspace. She is showing how bacteria communicate and socialize – and shaping it with sound. An Israeli-American multimedia artist, Nurit Bar-Shai composes video, live telematic installations and conducts experiments – working at the interface between art, science, and technology. She is also a co-founder and the Art and […]

June 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT